Blog Archives

Blog

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

Editor’s Note: Jiwon Oh provided research support for this article. She is a Certara Market…

CertaraMay 23, 2025

Blog

From Small Molecules to Biologics, New Modalities in Drug Development

Explore the dynamics of small molecules vs biologics in drug development, how their applications vary…

CertaraMay 22, 2025

Blog

CERTAINTY 2025: The power of Model-Informed Drug Development

We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…

CertaraMay 16, 2025

Blog Knowledge Base

Extrapolating AUC to Infinity

AUC calculations are simple but nuanced. In this blog, we look at how to extrapolate…

CertaraMay 15, 2025

Blog

QSP Summit 2025: A New Standard in the Future of Drug Development

May 5, 2025 The Quantitative Systems Pharmacology (QSP) Summit 2025, hosted by Certara, marked another…

CertaraMay 5, 2025

Blog

The State of Adopting AI in Drug Discovery in 2025

Assessing the current state of adopting AI in drug discovery with Jan Christopherson and Adrian…

CertaraApril 29, 2025

Blog

SEND V4.0 – What to Expect and When to Expect It

April 24, 2025 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…

CertaraApril 24, 2025

Blog

Managing Clinical Metadata for your Vendors, Studies, and Datasets

April 21, 2025 Clinical research is witnessing an evolution, driven by the increasing complexities of…

CertaraApril 21, 2025

Blog

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

April 18, 2025 What’s next for drug development? Recapping our MIDD in the age of…

CertaraApril 18, 2025

Blog

Using SDTM Data to Produce Patient Narratives

In this blog, we look at how medical writers can use SDTM data produced by…

CertaraApril 15, 2025

Blog

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

From Small Molecules to Biologics, New Modalities in Drug Development

CERTAINTY 2025: The power of Model-Informed Drug Development

Extrapolating AUC to Infinity

QSP Summit 2025: A New Standard in the Future of Drug Development

The State of Adopting AI in Drug Discovery in 2025

SEND V4.0 – What to Expect and When to Expect It

Managing Clinical Metadata for your Vendors, Studies, and Datasets

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

Using SDTM Data to Produce Patient Narratives

Newsletter sign up

Quick links

Solutions

Contact